ClinConnect ClinConnect Logo
Search / Trial NCT06287879

Function and Morphological Characteristics of Meibomian Gland in Patients With Renal Anemia

Launched by ZHONGNAN HOSPITAL · Feb 27, 2024

Trial Information

Current as of July 09, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying how kidney-related anemia affects the meibomian glands, which are important for keeping our eyes moist. Patients with renal anemia often experience dry eye symptoms, and this study aims to better understand how their meibomian glands function and look under these conditions. The trial is currently looking for participants who are between 16 and 90 years old and have been using medications like Roxadustat or erythropoietin for their anemia.

To be eligible for the study, participants should not wear contact lenses, have had recent eye surgeries, or have other health issues that could affect their eye health. If you join this trial, you can expect to share your medical history and undergo some eye examinations to help researchers learn more about the relationship between renal anemia and dry eyes. This information could lead to better treatments for those experiencing these symptoms in the future.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • long-term use of Roxadustat or erythropoietin for renal anemia
  • Exclusion Criteria:
  • contact lens wearer, history of eye surgeries, systemic health conditions affecting ocular health and those who were unable to cooperate with examinations

About Zhongnan Hospital

Zhongnan Hospital, affiliated with Wuhan University, is a leading medical institution in China renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a focus on multidisciplinary collaboration, the hospital employs state-of-the-art facilities and a team of highly skilled professionals to conduct rigorous clinical studies aimed at improving patient outcomes. Zhongnan Hospital prioritizes ethical standards and patient safety, ensuring adherence to regulatory requirements while fostering a culture of scientific excellence. As a prominent sponsor of clinical trials, the hospital plays a pivotal role in contributing to the global medical community and enhancing the understanding of various health conditions.

Locations

Wuhan, Hubei, China

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported